T1DM Therapeutics in Major Developed Markets Forecast to Year 2021 3 | Page 7

7.2 Market Forecasts to 2021 140
7.2.1 Global 140
7.2.2 US 141
7.2.3 Canada 141
7.2.4 UK 141
7.2.5 France 142
7.2.6 Germany 142
7.2.7 Italy 142
7.2.8 Spain 143
7.2.9 Japan 143
7.3 References 143
7.4 Heat Map References 153
7.5 Abbreviations 154
7.6 Research Methodology 156
7.7 Secondary Research 156
7.8 Marketed Product Profiles 157
7.9 Late-Stage Pipeline Candidates 157
7.10 Comparative Efficacy and Safety Heat Map for Marketed and Pipeline Products 157
7.11 Product Competitiveness Framework 157
7.12 Pipeline Analysis 157
7.12.1 Overall Pipeline 157
7.12.2 Clinical Trials 158
7.12.3 Failure Rate 158
7.12.4 Clinical Trial Size 158
7.12.5 Clinical Trial Duration 158